Peter Navarro: ‘I Bet On Trump’s Intuition’ Over Science When It Comes To Treatment Of COVID-19

From Crooks and Liars (video at the link):

Peter Navarro, Trump’s Director of Trade and Manufacturing Policy, who now is identifying as a social scientist, made the rounds on television today… after it was reported that he got into a heated confrontation with Dr. Fauci in a green room over the use of hydroxychloroquine on the coronavirus.

Earlier this morning on Fox and Friends, Navarro was reciting his Kellyanne Conway-prepared alternative facts and talking points about the anti-malaria drug, when co-host Ainsley Earhardt brought up the good Dr F.

In an annoyed tone she asked, “So what does Dr. Fauci want, does he want more testing?”

What a pain in the ass that Dr. Fauci is. How dare he slow Trump’s roll after the stable genius bragged about hydroxychloroquine.

Navarro knows exactly what Dr. Fauci’s objections are to administering hydroxychloroquine without verifiable results, but Navarro just stated he will let the medical professional speak for himself.

“He takes the view that is important to have control studies, randomized studies and go through the science and come to the end and determine what’s going on,” Navarro said.

You mean like a true medical professional? Like someone whose oath is ‘first do no harm?’

Navarro brought up the fact that he was a social scientist again and how he agrees with having real testing to see if a drug is an effective treatment.

Navarro claimed that we are in a war and that Trump is a wartime president.

He said, “In the fog of war we might take more risks than we otherwise would.”

White House fight over Hydroxychloroquine

This is bad. Really bad. Fauci is on thin ice. It’s just a matter of time before Trump pushes him out since Fauci has the audacity to believe in science and facts over an impeached president and failed businessman:

The White House coronavirus task force had its biggest fight yet on Saturday, pitting economic adviser Peter Navarro against infectious disease expert Anthony Fauci. At issue: How enthusiastically should the White House tout the prospects of an antimalarial drug to fight COVID-19?

Behind the scenes: This drama erupted into an epic Situation Room showdown. Trump’s coronavirus task force gathered in the White House Situation Room on Saturday at about 1:30pm, according to four sources familiar with the conversation. Vice President Mike Pence sat at the head of the table.

Numerous government officials were at the table, including Fauci, coronavirus response coordinator Deborah Birx, Jared Kushner, acting Homeland Security Secretary Chad Wolf, and Commissioner of Food and Drugs Stephen Hahn.
Behind them sat staff, including Peter Navarro, tapped by Trump to compel private companies to meet the government’s coronavirus needs under the Defense Production Act.

Toward the end of the meeting, Hahn began a discussion of the malaria drug hydroxychloroquine, which Trump believes could be a “game-changer” against the coronavirus.

Hahn gave an update about the drug and what he was seeing in different trials and real-world results.
Then Navarro got up. He brought over a stack of folders and dropped them on the table. People started passing them around.
“And the first words out of his mouth are that the studies that he’s seen, I believe they’re mostly overseas, show ‘clear therapeutic efficacy,'” said a source familiar with the conversation. “Those are the exact words out of his mouth.”

Navarro’s comments set off a heated exchange about how the Trump administration and the president ought to talk about the malaria drug, which Fauci and other public health officials stress is unproven to combat COVID-19.

Fauci pushed back against Navarro, saying that there was only anecdotal evidence that hydroxychloroquine works against the coronavirus.
Researchers have said studies out of France and China are inadequate because they did not include control groups.
Fauci and others have said much more data is needed to prove that hydroxychloroquine is effective against the coronavirus.
As part of his role, Navarro has been trying to source hydroxychloroquine from around the world. He’s also been trying to ensure that there are enough domestic production capabilities inside the U.S.